References
- Frey B, Weiss E-M, Rubner Y, et al. (2012). Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperthermia 28:528–42.
- Castagna A, Rinaldi S, Fontani V, et al. (2011). Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation. Clin Interv Aging 6:201.
- Giombini A, Giovannini V, Di Cesare A, et al. (2007). Hyperthermia induced by microwave diathermy in the management of muscle and tendon injuries. Brit Med Bull 83:379–96.
- Vertrees RA, Leeth A, Girouard M, et al. (2002). Whole-body hyperthermia: a review of theory, design and application. Perfusion 17:279–90.
- Wang W-C, Goldman LM, Schleider DM, et al. (1998). Fever-range hyperthermia enhances L-selectin-dependent adhesion of lymphocytes to vascular endothelium. J Immunol 160:961–9.
- Evans SS, Wang W-C, Bain MD, et al. (2001). Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood 97:2727–33.
- Ostberg J, Patel R, Repasky E. (2000). Regulation of immune activity by mild (fever-range) whole body hyperthermia: effects on epidermal Langerhans cells. Cell Stress Chaperones 5:458.
- Huang Y, Haegerstrand A, Frostegård J. (1996). Effects of in vitro hyperthermia on proliferative responses and lymphocyte activity. Clin Exp Immunol 103:61–6.
- Mace TA, Zhong L, Kokolus KM, Repasky EA. (2012). Effector CD8+ T cell IFN-γ production and cytotoxicity are enhanced by mild hyperthermia. Int J Hyperthermia 28:9–18.
- Calderwood SK, Theriault JR, Gong J. (2005). How is the immune response affected by hyperthermia and heat shock proteins? Int J Hyperthermia 21:713–16.
- Cho JA, Park H, Kim HK, et al. (2009). Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line. Cancer 115:311–23.
- Park H, Cho J-A, Kim S-K, et al. (2008). Hyperthermia on mesenchymal stem cells (MSCs) can sensitize tumor cells to undergo cell death. Int J Hyperthermia 24:638–48.
- Srivatanakul P. (2014). Mesenchymal stem cells. Bangkok Med J 6:71–9.
- Scheibe F, Ladhoff J, Huck J, et al. (2012). Immune effects of mesenchymal stromal cells in experimental stroke. J Cereb Blood Flow Metab 32:1578–88.
- Zuk PA, Zhu M, Ashjian P, et al. (2002). Human adipose tissue is a source of multipotent stem cells. Molec Biol Cell 13:4279–95.
- Uccelli A, Moretta L, Pistoia V. (2006). Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36:2566–73.
- Caplan AI. (2007). Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341–7.
- Abbas AK. (2015). Cellular and molecular immunology. Canada: Elsevier.
- Kadivar M, Khatami S, Mortazavi Y, et al. (2005). Isolation, culture and characterization of postnatal human umbilical vein-derived mesenchymal stem cells. DARU J Pharmaceut Sci 13:170–6.
- Rőszer T. (2015). Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediators Inflamm 2015:Article ID 816460. http://dx.doi.org/10.1155/2015/816460
- Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. (1996). Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184:1397.
- Dieing A, Ahlers O, Kerner T, et al. (2003). Whole body hyperthermia induces apoptosis in subpopulations of blood lymphocytes. Immunobiology 207:265–73.
- Tabera S, Pérez-Simón JA, Díez-Campelo M, et al. (2008). The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 93:1301–9.
- Jarvinen L, Badri L, Wettlaufer S, et al. (2008). Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. J Immunol 181:4389–96.
- Plumas J, Chaperot L, Richard M-J, et al. (2005). Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia 19:1597–604.
- Ramasamy R, Tong CK, Seow HF, et al. (2008). The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell Immunol 251:131–6.
- Matsui T, Kakeda T. (2008). IL-10 production is reduced by hypothermia but augmented by hyperthermia in rat microglia. J Neurotrauma 25:709–15.
- Flanders KC, Winokur TS, Holder MG, Sporn M. (1993). Hyperthermia induces expression of transforming growth factor-beta s in rat cardiac cells in vitro and in vivo. J Clin Invest 92:404.
- Engela AU, Hoogduijn MJ, Boer K, et al. (2013). Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNA. Clin Exp Immunol 173:343–54.
- Mohajeri M, Farazmand A, Bonab MM, et al. (2011). FOXP3 gene expression in multiple sclerosis patients pre- and post mesenchymal stem cell therapy. Iran J Allergy Asthma Immunol 10:155–61.
- Ostberg JR, Taylor SL, Baumann H, Repasky EA. (2000). Regulatory effects of fever-range whole-body hyperthermia on the LPS-induced acute inflammatory response. J Leukocyte Biol 68:815–20.
- Aggarwal S, Pittenger MF. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815–22.
- Lis R, Touboul C, Mirshahi P, et al. (2011). Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12. Int J Cancer 128:715–25.